FDA 483 - Catalent Pharma Solutions, LLC - February 22, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Catalent Pharma Solutions, LLC in Saint Petersburg, FL, revealed significant deficiencies across their laboratory and production systems. The firm failed to adhere to its written stability testing program, utilized an inadequate dissolution test method for a drug product, and did not follow or properly document written production and process control procedures. These issues indicate a lack of adherence to established quality and manufacturing standards.
ID · c760f7e9-a3ed-4068-8e39-cf085acfd8af